Derek de WinterE. J. T. VerweijAnne DebeerRoland DevliegerLiesbeth LewiSarah VerbeeckP MauriceJean‐Marie JouannicMarie-Gabrielle GuilleminAgnès Mailloux2026-03-222026-03-22202510.1001/jamanetworkopen.2024.54330https://doi.org/10.1001/jamanetworkopen.2024.54330https://andeanlibrary.org/handle/123456789/46109Citaciones: 9In this cohort study of neonates with HDFN managed at 31 centers in 22 countries, significant practice variations in the postnatal management of HDFN were identified, highlighting the lack of, and need for, consensus. The study suggests that there is a potential beneficial clinical association of waiting for delivery until after 37 weeks and 0 days with frequency of exchange transfusions among neonates with HDFN. The framework to implement international guidelines is provided.enFetusHemolytic disease of the newborn (ABO)DiseaseMedicinePregnancyarticle